SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-011587
Filing Date
2021-08-13
Accepted
2021-08-13 09:16:05
Documents
57
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q capr-20210630x10q.htm   iXBRL 10-Q 1402417
2 EX-10.1 capr-20210630xex10d1.htm EX-10.1 295403
3 EX-10.2 capr-20210630xex10d2.htm EX-10.2 128555
4 EX-10.3 capr-20210630xex10d3.htm EX-10.3 94946
5 EX-31.1 capr-20210630xex31d1.htm EX-31.1 9524
6 EX-31.2 capr-20210630xex31d2.htm EX-31.2 9386
7 EX-32.1 capr-20210630xex32d1.htm EX-32.1 5744
8 EX-32.2 capr-20210630xex32d2.htm EX-32.2 5705
  Complete submission text file 0001558370-21-011587.txt   5885669

Data Files

Seq Description Document Type Size
9 EX-101.SCH capr-20210630.xsd EX-101.SCH 47881
10 EX-101.CAL capr-20210630_cal.xml EX-101.CAL 28457
11 EX-101.DEF capr-20210630_def.xml EX-101.DEF 165688
12 EX-101.LAB capr-20210630_lab.xml EX-101.LAB 360947
13 EX-101.PRE capr-20210630_pre.xml EX-101.PRE 291240
14 EXTRACTED XBRL INSTANCE DOCUMENT capr-20210630x10q_htm.xml XML 715446
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34058 | Film No.: 211169965
SIC: 2834 Pharmaceutical Preparations